Search

Your search keyword '"Kojima, Kensuke"' showing total 900 results

Search Constraints

Start Over You searched for: Author "Kojima, Kensuke" Remove constraint Author: "Kojima, Kensuke"
900 results on '"Kojima, Kensuke"'

Search Results

3. Real-world data of MDS and CMML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11)

5. Real-world data of AML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11)

8. Targeting cis-regulatory elements of FOXO family is a novel therapeutic strategy for induction of leukemia cell differentiation

10. Algorithms and Hardness Results for the Maximum Balanced Connected Subgraph Problem

12. BDDs Naturally Represent Boolean Functions, and ZDDs Naturally Represent Sets of Sets

16. Sharper and Simpler Nonlinear Interpolants for Program Verification

19. Generalized Homogeneous Polynomials for Efficient Template-Based Nonlinear Invariant Synthesis

21. Real-world data of MDS and CMML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11)

23. Enhanced TP53 reactivation disrupts MYC transcriptional program and overcomes venetoclax resistance in acute myeloid leukemias

24. Real-world data of AML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11)

29. Clinical impact of the CONUT score in patients with multiple myeloma

30. Imipridone ONC212 activates orphan G protein-coupled receptor GPR132 and integrated stress response in acute myeloid leukemia

31. A Nonstandard Functional Programming Language

32. Feasibility of the imatinib stop study in the Japanese clinical setting: delightedly overcome CML expert stop TKI trial (DOMEST Trial)

34. Automated Verification of Functional Correctness of Race-Free GPU Programs

43. Supplemental File 3 from Predictive Gene Signatures Determine Tumor Sensitivity to MDM2 Inhibition

44. Supplemental File 1 from Predictive Gene Signatures Determine Tumor Sensitivity to MDM2 Inhibition

45. Supplemental File 2 from Predictive Gene Signatures Determine Tumor Sensitivity to MDM2 Inhibition

46. Supplemental Information from Predictive Gene Signatures Determine Tumor Sensitivity to MDM2 Inhibition

47. Supplemental Figures 1 and 2 from Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia

48. Data from Predictive Gene Signatures Determine Tumor Sensitivity to MDM2 Inhibition

49. Supplemental Methods from Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia

Catalog

Books, media, physical & digital resources